Individualized Cost-Effectiveness Analysis
Author Information
Author(s): John P. A. Ioannidis, Alan M. Garber
Primary Institution: Stanford University School of Medicine
Hypothesis
How can incremental cost-effectiveness ratios (ICER) be modified for individual decision-making?
Conclusion
Individualized cost-effectiveness analyses can provide more relevant information for clinicians and patients than traditional ICERs.
Supporting Evidence
- ICERs are useful for population-level decisions but have limitations for individual choices.
- Different individuals may prioritize outcomes differently, affecting cost-effectiveness.
- Providing additional metrics can enhance the usefulness of cost-effectiveness analyses.
Takeaway
This study talks about how to make cost-effectiveness analysis more personal, so that doctors and patients can make better choices based on their own needs.
Methodology
The authors discuss the limitations of traditional ICERs and propose ways to present individualized cost-effectiveness information.
Potential Biases
Potential biases may arise from conflicts of interest or unrealistic modeling assumptions.
Limitations
The study acknowledges that individualized analyses may not always be necessary or appropriate and can be subject to errors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website